{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:04:42Z","timestamp":1790593482765,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006227","name":"Lawrence Livermore National Laboratory","doi-asserted-by":"publisher","award":["DE-AC52-07NA27344"],"award-info":[{"award-number":["DE-AC52-07NA27344"]}],"id":[{"id":"10.13039\/100006227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R61NS123195"],"award-info":[{"award-number":["R61NS123195"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.molpha.2026.100149","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:36:11Z","timestamp":1785368171000},"page":"100149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Piezo1 agonists are potent off-target inhibitors of the Kv1.3 channel via gating modification"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2010-5080","authenticated-orcid":false,"given":"Kyan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesung","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-5763","authenticated-orcid":false,"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1422-7041","authenticated-orcid":false,"given":"Hai M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity","volume":"33","author":"Feske","year":"2015","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-bioeng-062117-121224","article-title":"Mechanobiology of macrophages: how physical factors coregulate macrophage plasticity and phagocytosis","volume":"21","author":"Jain","year":"2019","journal-title":"Annu Rev Biomed Eng"},{"issue":"6000","key":"10.1016\/j.molpha.2026.100149_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.1193270","article-title":"Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels","volume":"330","author":"Coste","year":"2010","journal-title":"Science"},{"issue":"7388","key":"10.1016\/j.molpha.2026.100149_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nature10812","article-title":"Piezo proteins are pore-forming subunits of mechanically activated channels","volume":"483","author":"Coste","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tibs.2016.09.004","article-title":"Touch, tension, and transduction - the function and regulation of Piezo ion channels","volume":"42","author":"Wu","year":"2017","journal-title":"Trends Biochem Sci"},{"issue":"7772","key":"10.1016\/j.molpha.2026.100149_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-019-1485-8","article-title":"Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity","volume":"573","author":"Solis","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib7","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41467-021-23482-5","article-title":"Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing","volume":"12","author":"Atcha","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2026.100149_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07369","article-title":"Chemical activation of the mechanotransduction channel Piezo1","volume":"4","author":"Syeda","year":"2015","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib9","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/s41467-019-12501-1","article-title":"A mechanism for the activation of the mechanosensitive Piezo1 channel by the small molecule Yoda1","volume":"10","author":"Botello-Smith","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.molpha.2026.100149_bib10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.121.18750","article-title":"Myeloid Piezo1 deletion protects renal fibrosis by restraining macrophage infiltration and activation","volume":"79","author":"He","year":"2022","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.molpha.2026.100149_bib11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/glia.24311","article-title":"Piezo1 channel-mediated Ca2+ signaling inhibits lipopolysaccharide-induced activation of the NF-\u03baB inflammatory signaling pathway and generation of TNF-\u03b1 and IL-6 in microglial cells","volume":"71","author":"Malko","year":"2023","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.molpha.2026.100149_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.105993","article-title":"The mechanosensitive ion channel Piezo1 modulates the migration and immune response of microglia","volume":"26","author":"Zhu","year":"2023","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.molpha.2026.100149_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101495","article-title":"Piezo1-specific deletion in macrophage protects the progression of chronic inflammatory bowel disease in mice","volume":"19","author":"Wang","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.molpha.2026.100149_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116050","article-title":"Dexamethasone upregulates macrophage PIEZO1 via SGK1, suppressing inflammation and increasing ROS and apoptosis","volume":"222","author":"Liu","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13206-025-00228-9","article-title":"Piezo1 activation promotes glial anti-inflammation and tau dephosphorylation in an Alzheimer\u2019s disease model","volume":"20","author":"Zhu","year":"2025","journal-title":"BioChip J"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","article-title":"The functional network of ion channels in T lymphocytes","volume":"231","author":"Cahalan","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.molpha.2026.100149_bib17","series-title":"Ion Channels as Targets in Drug Discovery","first-page":"461","article-title":"Immune cell ion channels as therapeutic targets","author":"Selezneva","year":"2024"},{"issue":"4","key":"10.1016\/j.molpha.2026.100149_bib18","doi-asserted-by":"crossref","first-page":"L862","DOI":"10.1152\/ajplung.00095.2003","article-title":"Kv1.3 potassium channels in human alveolar macrophages","volume":"285","author":"Mackenzie","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41420-025-02508-7","article-title":"Therapeutic potential of voltage-dependent potassium channel subtype 1.3 blockade in alleviating macrophage-related renal inflammation and fibrogenesis","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.molpha.2026.100149_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3233\/JAD-141704","article-title":"Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer\u2019s disease","volume":"44","author":"Rangaraju","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.molpha.2026.100149_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/brain\/awx346","article-title":"Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer\u2019s disease: preclinical proof of concept","volume":"141","author":"Maezawa","year":"2018","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.molpha.2026.100149_bib22","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/glia.23847","article-title":"Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia","volume":"68","author":"Nguyen","year":"2020","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.molpha.2026.100149_bib23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100149_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00395-020-00834-8","article-title":"Hyperglycemia regulates cardiac K+ channels via O-GlcNAc-CaMKII and NOX2-ROS-PKC pathways","volume":"115","author":"Hegyi","year":"2020","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/glia.23078","article-title":"Differential Kv1.3, KCa3.1, and Kir2.1 expression in \u201cclassically\u201d and \u201calternatively\u201d activated microglia","volume":"65","author":"Nguyen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.molpha.2026.100149_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32417","article-title":"T-cell calcium dynamics visualized in a ratiometric tdTomato-GCaMP6f transgenic reporter mouse","volume":"6","author":"Dong","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.molpha.2026.100149_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.niox.2020.04.005","article-title":"Isolation and culture of murine bone marrow-derived macrophages for nitric oxide and redox biology","volume":"100\u2013101","author":"Bailey","year":"2020","journal-title":"Nitric Oxide"},{"issue":"16","key":"10.1016\/j.molpha.2026.100149_bib28","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/bph.15996","article-title":"Improved PIEZO1 agonism through 4-benzoic acid modification of Yoda1","volume":"180","author":"Parsonage","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.molpha.2026.100149_bib29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/prot.21086","article-title":"ROSETTALIGAND: protein\u2013small molecule docking with full side-chain flexibility","volume":"65","author":"Meiler","year":"2006","journal-title":"Proteins"},{"issue":"7","key":"10.1016\/j.molpha.2026.100149_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.molpha.2026.100149_bib31","first-page":"10","article-title":"ImageJ\/Fiji ROI 1-click tools for rapid manual image annotations and measurements","volume":"2020","author":"Thomas","year":"2020","journal-title":"MicroPubl Biol"},{"issue":"10","key":"10.1016\/j.molpha.2026.100149_bib32","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/bph.14188","article-title":"Yoda1 analogue (Dooku1) which antagonizes Yoda1-evoked activation of Piezo1 and aortic relaxation","volume":"175","author":"Evans","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.molpha.2026.100149_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0896-6273(91)90367-9","article-title":"Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region","volume":"7","author":"Hoshi","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2026.100149_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.924289","article-title":"Mechanisms underlying C-type inactivation in Kv channels: lessons from structures of human Kv1.3 and fly Shaker-IR channels","volume":"13","author":"Ong","year":"2022","journal-title":"Front Pharmacol"},{"issue":"Pt 2","key":"10.1016\/j.molpha.2026.100149_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1469-7793.1998.291bw.x","article-title":"Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states","volume":"506","author":"J\u00e4ger","year":"1998","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.molpha.2026.100149_bib36","doi-asserted-by":"crossref","first-page":"C1067","DOI":"10.1152\/ajpcell.00438.2003","article-title":"pH-dependent modulation of Kv1.3 inactivation: role of His399","volume":"287","author":"Somodi","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100149_bib37","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0026-895X(25)09629-4","article-title":"Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation","volume":"50","author":"Nguyen","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.molpha.2026.100149_bib38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjp.0702480","article-title":"UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation","volume":"126","author":"Hanson","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100149_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113536119","article-title":"Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug","volume":"119","author":"Tyagi","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib40","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1038\/s41467-022-31285-5","article-title":"Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators","volume":"13","author":"Selvakumar","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2026.100149_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01289","article-title":"Hydrogen bonds as molecular timers for slow inactivation in voltage-gated potassium channels","volume":"2","author":"Pless","year":"2013","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.molpha.2026.100149_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0896-6273(93)90190-3","article-title":"Gating currents from a nonconducting mutant reveal open-closed conformations in Shaker K+ channels","volume":"11","author":"Perozo","year":"1993","journal-title":"Neuron"},{"issue":"49","key":"10.1016\/j.molpha.2026.100149_bib43","doi-asserted-by":"crossref","first-page":"31013","DOI":"10.1074\/jbc.271.49.31013","article-title":"The signature sequence of voltage-gated potassium channels projects into the external vestibule","volume":"271","author":"Aiyar","year":"1996","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.molpha.2026.100149_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1085\/jgp.110.2.87","article-title":"Allosteric effects of permeating cations on gating currents during K+ channel deactivation","volume":"110","author":"Chen","year":"1997","journal-title":"J Gen Physiol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100149_bib45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1085\/jgp.109.6.779","article-title":"How does the W434F mutation block current in Shaker potassium channels?","volume":"109","author":"Yang","year":"1997","journal-title":"J Gen Physiol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep45310","article-title":"Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit","volume":"7","author":"Kubota","year":"2017","journal-title":"Sci Rep"},{"issue":"47","key":"10.1016\/j.molpha.2026.100149_bib47","doi-asserted-by":"crossref","first-page":"46307","DOI":"10.1074\/jbc.M304388200","article-title":"Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages","volume":"278","author":"Vicente","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"6344","key":"10.1016\/j.molpha.2026.100149_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3222","article-title":"An environment-dependent transcriptional network specifies human microglia identity","volume":"356","author":"Gosselin","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.molpha.2026.100149_bib50","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4049\/jimmunol.1701118","article-title":"Cutting edge: Piezo1 mechanosensors optimize human T cell activation","volume":"200","author":"Liu","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.molpha.2026.100149_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.976482","article-title":"Ion channel Piezo1 activation promotes aerobic glycolysis in macrophages","volume":"13","author":"Leng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.molpha.2026.100149_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1149336","article-title":"Mechanosensitive Piezo1 protein as a novel regulator in macrophages and macrophage-mediated inflammatory diseases","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12974-022-02486-y","article-title":"Microglial amyloid beta clearance is driven by PIEZO1 channels","volume":"19","author":"J\u00e4ntti","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","article-title":"Microglial Piezo1 senses A\u03b2 fibril stiffness to restrict Alzheimer\u2019s disease","volume":"111","author":"Hu","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.immuni.2017.11.026","article-title":"Chanzyme TRPM7 mediates the Ca2+ influx essential for lipopolysaccharide-induced toll-like receptor 4 endocytosis and macrophage activation","volume":"48","author":"Schappe","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib56","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/s41598-018-36052-5","article-title":"Elevated pre-activation basal level of nuclear NF-\u03baB in native macrophages accelerates LPS-induced translocation of cytosolic NF-\u03baB into the cell nucleus","volume":"9","author":"Bagaev","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.molpha.2026.100149_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","article-title":"NF-\u03baB signaling in macrophages: dynamics, crosstalk, and signal integration","volume":"10","author":"Dorrington","year":"2019","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.molpha.2026.100149_bib58","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1111\/bph.17351","article-title":"Pharmacology of PIEZO1 channels","volume":"181","author":"Kinsella","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100149_bib59","doi-asserted-by":"crossref","first-page":"C1652","DOI":"10.1152\/ajpcell.00457.2025","article-title":"Activation of the Piezo1 channel stimulates protein kinase D and migration in human aortic endothelial cells","volume":"329","author":"Lone","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.molpha.2026.100149_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1423410","article-title":"Microglial Piezo1 mechanosensitive channel as a therapeutic target in Alzheimer\u2019s disease","volume":"18","author":"Ikiz","year":"2024","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1113\/jphysiol.1985.sp015548","article-title":"A voltage-gated potassium channel in human T lymphocytes","volume":"358","author":"Cahalan","year":"1985","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib62","first-page":"61","article-title":"Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels","volume":"1","author":"L\u00f3pez-Barneo","year":"1993","journal-title":"Recept Channels"},{"issue":"3","key":"10.1016\/j.molpha.2026.100149_bib63","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0006-3495(95)79963-5","article-title":"C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism","volume":"69","author":"Panyi","year":"1995","journal-title":"Biophys J"},{"issue":"Pt 2","key":"10.1016\/j.molpha.2026.100149_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1113\/jphysiol.1997.sp021933","article-title":"Pore mutations in Shaker K+ channels distinguish between the sites of tetraethylammonium blockade and C-type inactivation","volume":"499","author":"Molina","year":"1997","journal-title":"J Physiol"},{"issue":"Pt 2","key":"10.1016\/j.molpha.2026.100149_bib65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1469-7793.1998.327bn.x","article-title":"Pore mutations alter closing and opening kinetics in Shaker K+ channels","volume":"509","author":"Molina","year":"1998","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100149_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41421-021-00269-y","article-title":"Structures of wild-type and H451N mutant human lymphocyte potassium channel KV1.3","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discov"},{"issue":"11","key":"10.1016\/j.molpha.2026.100149_bib67","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","article-title":"The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS","volume":"111","author":"Wulff","year":"2003","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.molpha.2026.100149_bib68","first-page":"4195","article-title":"Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"130","author":"Sarkar","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.molpha.2026.100149_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1190476","article-title":"Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke","volume":"14","author":"Lee","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:32:02Z","timestamp":1790591522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0026895X26000490"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100149","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Piezo1 agonists are potent off-target inhibitors of the Kv1.3 channel via gating modification","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100149"}}